340 results on '"Preuss, Klaus-Dieter"'
Search Results
2. Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies
3. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study
4. LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome
5. Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
6. Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
7. Characterization of rare germline variants in familial multiple myeloma
8. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma
9. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
10. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
11. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
12. The molecular basis for development of proinflammatory autoantibodies to progranulin
13. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells
14. IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination
15. Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells
16. Progranulin antibodies in autoimmune diseases
17. B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens
18. Autoantibodies against SUMO1-DHX35 in long-COVID
19. The impact of Fc-γ receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab
20. Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A
21. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenström macroglobulinemia
22. Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor
23. Proinflammatory Progranulin Antibodies in Inflammatory Bowel Diseases
24. Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study
25. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case–control study
26. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells.
27. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors
28. Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19
29. Autoantibodies against IL-1-receptor-antagonist in multisystem inflammatory syndrome in children
30. Inactivation of protein-phosphatase 2A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS/MM is due to an exchange of its regulatory subunits
31. Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM
32. Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens
33. Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas
34. The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
35. Analysis of the antibody repertoire of lymphoma patients
36. Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma
37. Role of Specific B-Cell Receptor Antigens in Lymphomagenesis
38. Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma
39. Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuria
40. Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells
41. Human tumor antigens recognized by antibodies (SEREX)
42. Identification of antigenic targets of paraproteins by expression cloning does not support a causal role of chronic antigenic stimulation in the pathogenesis of multiple myeloma and MGUS
43. Mitofilin and titin as target antigens in melanoma-associated retinopathy
44. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer
45. B-cell epitopes from the cancer testis antigen NY-ESO-1
46. Role of specific B-cell receptor antigens in lymphomagenesis
47. A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4+ and CD8+ T-cell as well as B-cell responses
48. Analysis of the B-cell repertoire against antigens expressed by human neoplasms
49. Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study
50. The B-Cell Receptor Antigen ARS2 Can be Integrated into a BAR-Body Format to Treat Diffuse Large B-Cell Lymphomas in Xenograft Mouse Models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.